Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial.

Saad F, Fizazi K, Jinga V, Efstathiou E, Fong PC, Hart LL, Jones R, McDermott R, Wirth M, Suzuki K, MacLean DB, Wang L, Akaza H, Nelson J, Scher HI, Dreicer R, Webb IJ, de Wit R; ELM-PC 4 investigators.

Lancet Oncol. 2015 Mar;16(3):338-48. doi: 10.1016/S1470-2045(15)70027-6. Epub 2015 Feb 18.

PMID:
25701170
2.

Routine diagnostic ureteroscopy for suspected upper tract transitional-cell carcinoma.

Tsivian A, Tsivian M, Stanevsky Y, Tavdy E, Sidi AA.

J Endourol. 2014 Aug;28(8):922-5. doi: 10.1089/end.2013.0703. Epub 2014 May 15.

PMID:
24742232

Supplemental Content

Loading ...
Support Center